Zevra Therapeutics, Inc.
NASDAQ:ZVRABiotechnology
Healthcare
$9.28 +2.44%
+$0.31 today
- Market cap
- $552.20M
- Beta
- 0.89
- P/E (TTM)
- 6.1
- EPS (TTM)
- $2.13
52W Low $7.16High $14.27
Volume 0.62M
Average 1.43M
Price history
Zevra Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-4.33%
Period high
$14.75
Period low
$8.10
Latest
$9.28
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Nov 3, 2026 | Nov 3, 2026 | |
| 8-K | Nov 3, 2026 | Nov 3, 2026 | |
| 4 | Oct 13, 2026 | Oct 13, 2026 | |
| 4 | Aug 17, 2026 | Aug 17, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| 4 | Aug 12, 2026 | Aug 12, 2026 | |
| SC 13G/A | Aug 6, 2026 | Aug 6, 2026 | |
| 10-Q | Aug 5, 2026 | Aug 5, 2026 | |
| 8-K | Aug 5, 2026 | Aug 5, 2026 | |
| SC 13G | Jul 31, 2026 | Jul 31, 2026 | |
| 4 | Jun 23, 2026 | Jun 23, 2026 | |
| 4 | Jun 18, 2026 | Jun 18, 2026 | |
| 4 | Jun 18, 2026 | Jun 18, 2026 | |
| 4 | Jun 18, 2026 | Jun 18, 2026 |
Competitors
Who does Zevra Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about ZVRA's filings, answered from its disclosures.
What is the latest ZVRA filing?
The latest filing shown is SC 13G/A dated Nov 5, 2026.
How many recent filings does ZVRA have?
Intrinsic Alpha currently shows 20 recent filings for ZVRA.
Continue the stock analysis
Jump to another research area for this company.